Advertisement
Advertisement

NKTX

NKTX logo

Nkarta, Inc. Common Stock

2.90
USD
Sponsored
0.00
+0.17%
Jun 25, 12:00 UTC -4
Open

NKTX Earnings Reports

Positive Surprise Ratio

NKTX beat 13 of 24 last estimates.

54%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.38
Implied change from Q1 26 (Revenue/ EPS)
--
/
+2.70%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+22.58%

Nkarta, Inc. Common Stock earnings per share and revenue

On May 12, 2026, NKTX reported earnings of -0.37 USD per share (EPS) for Q1 26, beating the estimate of -0.38 USD, resulting in a 2.63% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.71% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 6 analysts forecast an EPS of -0.38 USD, with revenue projected to reach -- USD, implying an increase of 2.70% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Nkarta, Inc. Common Stock reported EPS of -$0.37, beating estimates by 2.63%, and revenue of $0.00, 0% as expectations.
The stock price moved down -6.71%, changed from $3.28 before the earnings release to $3.06 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 6 analysts, Nkarta, Inc. Common Stock is expected to report EPS of -$0.38 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement